Metabolic & GLP-1 Peptide Research

An overview of Tirzepatide’s dual GLP-1 and GIP receptor mechanism and its significance in metabolic research.

A receptor-level comparison of Semaglutide, Tirzepatide, and Retatrutide — covering structural differences, signalling profiles, and research compound selection guidance.

A research-focused overview of how GIP and GLP-1 incretin hormones coordinate appetite suppression, insulin secretion, and glucose homeostasis — and why they are central to metabolic peptide science.

Retatrutide targets three metabolic receptors — GLP-1, GIP, and glucagon — through a single molecule. This article explains how each pathway contributes to its unique research profile.

A detailed scientific breakdown of how Tirzepatide engages GIP and GLP-1 receptors simultaneously, and what this dual incretin signalling means for metabolic research.

An in-depth comparison of GIP and GLP-1 receptors, their distinct signalling roles, and why dual agonism represents a significant advance in metabolic research.

A comprehensive mechanistic overview of GLP-1 receptor agonists — how they bind, signal, and influence metabolic pathways in research settings.

A research-level review of how GLP-1, GIP, and glucagon receptor agonism affect white and brown adipose tissue biology, including adipokine secretion, lipolysis signalling, and BAT thermogenesis.

A deep dive into glucagon receptor biology and what GCGR agonism uniquely contributes to multi-target metabolic peptide research — including energy expenditure, hepatic lipid metabolism, and BAT thermogenesis.

A research-focused overview of how incretin hormones GLP-1 and GIP regulate glucose homeostasis and appetite, with mechanistic detail on their pancreatic and CNS signalling pathways.